[FURL=https://www.industryarc.com/Report/16900/estrogen-replacement-therapy-ert-market.html?utm_source=briefingwire&utm_medium=pressrelease&utm_campaign=paidpressrelease]Estrogen Replacement Therapy (ERT) Market[/FURL] Estrogen Replacement Therapy (ERT) Market size is estimated to reach $12.3 billion by 2026, growing at a CAGR of 5.8% during the forecast period 2021-2026. Estrogen Replacement Therapy is a therapy that is most frequently used to treat various symptoms of menopause. Estrogen replacement therapies reduce and stop the differences in menopause, such as vaginal dryness and hot flashes. Estrogen replacement therapies are increasingly being used across the world owing to the growing prevalence of Prader-Willi syndrome and the rise in the availability of progesterone and estrogen hormone therapies.Key Takeaways
Geographically, the North America Estrogen Replacement Therapy (ERT) Market accounted for the highest revenue share in 2020, and it is poised to dominate over the period 2021-2026 owing to the rise in the prevalence of Prader-Willi Syndrome.
The increase in the demand for advanced dosage forms for progesterone and estrogen hormonal therapies is driving the Tablets segment. However, the high treatment cost of Estrogen Replacement Therapy (ERT) is one of the major factors that is said to reduce the growth of the Estrogen Replacement Therapy (ERT) Market.
Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Estrogen Replacement Therapy (ERT) Market report.
Download Sample Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=16900[/FURL]
Estrogen Replacement Therapy (ERT) Market Segment Analysis - By Geography
The Estrogen Replacement Therapy (ERT) Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and Rest of the World. North America held the largest share, with 36% of the overall market in 2020. The growth in this segment is owing to the factors such as the increasing demand for advanced drug delivery systems in developed regions and the growing prevalence of Prader-Willi Syndrome. The growing availability of different dosage forms for hormonal replacement therapies is driving the growth of the Estrogen Replacement Therapy (ERT) Market.
Estrogen Replacement Therapy (ERT) Market Drivers
Increase in the Effectiveness of Various Dosage Forms for Hormonal Replacement Therapies is Expected to Boost Product Demand
Rise in the Prevalence of Prader-Willi syndrome will Provide New Growth Avenues to the Industry Growth
Estrogen Replacement Therapy (ERT) Market Competitive Landscape:
Key companies of this market are AbbVie, Bayer AG, Hisamitsu Pharmaceutical Co Inc., Orion Pharma AB, Meda Pharmaceuticals, TherapeuticsMD, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Novartis AG, Novo Nordisk A/S
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.